[Fibrinolytic treatment with urokinase of post acute phlebothromboses (author's transl)].
Standardised urokinase-heparin treatment was administered to 32 patients one to six weeks after deep-vein thrombosis. Treatment generally continued over 7-14 days. Complete recanalisation occurred in six, partial in 18 patients. In eight patients there was no evidence of thrombolysis in the phlebogram.
D000328:Adult; D010450:Endopeptidases / Q000627:therapeutic use*; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D010690:Phlebography; D013924:Thrombophlebitis / Q000000981:diagnostic imaging / Q000188:drug therapy*; D013997:Time Factors; D014568:Urokinase-Type Plasminogen Activator / Q000008:administration & dosage / Q000627:therapeutic use*
D006493:Heparin; D010450:Endopeptidases; D014568:Urokinase-Type Plasminogen Activator
Ergebnisse der fibrinolytischen Therapie mit Urokinase bei älteren Phlebothrombosen.